Synthetic Strength: Positioning Biomanufacturing as a U.S. Strategic Asset episode artwork

EPISODE · Sep 10, 2025 · 34 MIN

Synthetic Strength: Positioning Biomanufacturing as a U.S. Strategic Asset

from Emerging Tech Horizons · host Dr. Arun Seraphin

Join guest host Dr. Liz Specht for a conversation with Matt Spence, the managing director and global head of venture capital banking at Barclays. In this episode Dr. Spence discusses the role food security plays in national security and how the government can incentivize and support biotechnology research and development. The episode explores how synthetic biology can be leveraged into additional defense uses and dispels common misconceptions about synthetic biology and national security.To receive updates about the conference please join our mailing list here: https://www.emergingtechnologiesinstitute.org/sign-uphttp://emergingtechnologiesinstitute.orghttps://www.facebook.com/EmergingTechETIhttps://www.linkedin.com/company/ndia-eti-emerging-technologies-institutehttps://www.twitter.com/EmergingTechETI

Episode metadata supplied by the publisher feed · Published Sep 10, 2025

Embed this episode

NOW PLAYING

Synthetic Strength: Positioning Biomanufacturing as a U.S. Strategic Asset

0:00 34:22

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Emerging Tech Horizons?

This episode is 34 minutes long.

When was this Emerging Tech Horizons episode published?

This episode was published on September 10, 2025.

Can I download this Emerging Tech Horizons episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!